Elicio Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Elicio Therapeutics, Inc. (ELTX) had Convertible Notes Payable, Noncurrent of $0 as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2025-05-13
- 2025-03-31: Convertible Notes Payable, Noncurrent $0.00.
- 2024-12-31: Convertible Notes Payable, Noncurrent $20.03M.
- 2023-12-31: Convertible Notes Payable, Noncurrent $0.00.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $20.03M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |